Skip to main content

Table 1 Expression of somatostatin receptors subtypes in some thyroid lesions – the previous studies

From: Expression of somatostatin receptor subtypes in human thyroid tumors: the immunohistochemical and molecular biology (RT-PCR) investigation

Lesion type

SSTR detected

Material

Methods

Authors

Follicular carcinoma

SSTR 1, 2A, 2B, 4, 5 -100%, SSTR 3-negative.

Formalin fixed paraffin embedded sections.

IHC

[12]

 

SSTR 1, 3 -moderate, SSTR 2-faint, SSTR 5-strong, SSTR 4-negative.

Thyroid cancer cell line monolayer and xenograft (MRO-87, WRO-82).

Semiquantitative RT-PCR with ethidium bromide.

[10]

Papillary carcinoma

SSTR 1, 2B, 3, 4 -83%; SSTR 2A-66%, SSTR 5–100%.

Formalin fixed paraffin embedded sections.

IHC

[12]

 

SSTR 1, 3, 5 -moderate, SSTR 2 – faintly detectable, SSTR 4 – negative.

Thyroid cancer cell line monolayer and xenograft (NPA 87, KAT-10).

Semiquantitative RT-PCR with ethidium bromide.

[10]

 

SSTR 2 -87%.

Paraffin embedded sections.

IHC

[13]

 

SSTR 2–68%, SSTR 5–50%, SSTR3 -31%, SSTR 1, 4 – not found.

Frozen tissue.

RT-PCR

[13]

 

SSTR 1, 3, 4, 5-more than twice the background, SSTR 2 -no signal.

Frozen biopsied tumor tissue.

Northern blot analysis.

[21]

Multinodular goiter (MNG)

SSTR 2A, 3, 4 -82%, SSTR 2B, 5–94%, SSTR 1–88%.

Formalin fixed paraffin embedded sections.

IHC

[12]